tiprankstipranks
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Financial Statements

83 Followers

Emmaus Life Sciences Financial Overview

Emmaus Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.093; its P/E ratio is -1.26; Emmaus Life Sciences is scheduled to report earnings on March 29, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 10.76M$ 6.75M$ 5.93M$ 4.94M$ 4.29M
Gross Profit$ 10.25M$ 6.32M$ 5.29M$ 4.40M$ 3.89M
EBIT$ 277.00K$ -1.98M$ 4.13M$ 1.09M$ -7.42M
EBITDA$ 970.00K$ -1.39M$ 4.66M$ 1.11M$ -7.41M
Net Income Common Stockholders$ -1.48M$ -3.50M$ 3.28M$ -391.00K$ -8.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.36M$ 1.77M$ 2.02M$ 1.18M$ 982.00K
Total Assets$ 50.30M$ 48.83M$ 48.23M$ 42.20M$ 45.99M
Total Debt$ 32.67M$ 33.00M$ 30.44M$ 34.23M$ 35.42M
Net Debt$ 31.30M$ 31.23M$ 28.42M$ 33.05M$ 34.44M
Total Liabilities$ 85.32M$ 84.90M$ 82.32M$ 79.79M$ 80.62M
Stockholders Equity$ -35.03M$ -35.95M$ -34.09M$ -37.59M$ -34.63M
Cash Flow-
Free Cash Flow$ -1.32M$ -1.29M$ 1.67M$ -954.00K$ -1.08M
Operating Cash Flow$ -1.32M$ -1.28M$ 1.68M$ -954.00K$ -1.06M
Investing Cash Flow$ 1.06M$ -1.09M$ -1.06M$ -900.00K$ -1.65M
Financing Cash Flow$ -153.00K$ 2.14M$ 170.00K$ 2.11M$ 2.89M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

Emmaus Life Sciences Debt to Assets

Emmaus Life Sciences Cash Flow

Emmaus Life Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis